TCG Advisors’s Medtronic MDT Stock Holding History

TCG Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-248	Closed	-$24K	–	289
2019 Q2	$24K	Buy	248 +1	+0.4%	+$91	0.02%	198
2019 Q1	$23K	Buy	+247	New	+$22.1K	0.02%	211

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCG Advisors's MDT Position: Q3 2019 in Review

TCG Advisors sold out of Medtronic (MDT) in Q3 2019, closing a stake of 248 shares — an estimated $24K sold.

TCG Advisors first reported a position in MDT in Q1 2019 and held it in 2 quarters. The position peaked at $24K in Q2 2019. 1,644 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

TCG Advisors reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
TCG Advisors sold 248 Medtronic shares in Q3 2019, an estimated $24K.
TCG Advisors first reported a position in Medtronic in Q1 2019 and held it in 2 quarters.
TCG Advisors's Medtronic position peaked at $24K in Q2 2019.
1,644 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on TCG Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.